NeuroPace (NPCE) Total Current Liabilities (2020 - 2026)

NeuroPace has reported Total Current Liabilities for 7 years, with the latest figure at $17.4 million in Q2 2026.

• On a quarterly basis, Total Current Liabilities rose 1.69% year-over-year to $17.4 million in Q2 2026; TTM through Jun 2026 was $17.4 million, a 1.69% increase from a year earlier, with the FY2025 full-year figure at $17.8 million, up 17.54% from the prior year.
• Total Current Liabilities was $17.4 million for Q2 2026 at NeuroPace, up from $16.2 million in the prior quarter.
• The five-year high for Total Current Liabilities was $19.6 million in Q3 2025, with the low at $9.4 million in Q3 2022.
• Average Total Current Liabilities over 5 years is $14.0 million, with a median of $13.9 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Total Current Liabilities jumped 49.82% in 2022, then dropped 18.1% in 2023.
• Over 5 years, Total Current Liabilities stood at $11.0 million in 2022, then surged by 47.86% to $16.2 million in 2023, then fell by 6.61% to $15.2 million in 2024, then rose by 17.54% to $17.8 million in 2025, then decreased by 2.14% to $17.4 million in 2026.
• The last three Total Current Liabilities figures came in at $17.4 million (Q2 2026), $16.2 million (Q1 2026), and $17.8 million (Q4 2025), per Business Quant data.